A
Market Data
$1.48−$0.18 (−11.14%)
AKBA · Last trade
Prev Close
$1.66
Range (30d)
$1.34 – $1.62
Recent Filings
- 8-K4.2 MBAkebia Therapeutics, Inc.Jan 12, 8:04 AM ET·0001517022-26-000003
- 8-K219.2 KBAkebia Therapeutics, Inc.Dec 1, 7:08 AM ET·0001517022-25-000051
- 8-K159.7 KBAkebia Therapeutics, Inc.Nov 17, 7:54 AM ET·0001517022-25-000048
- 10-Q10.8 MBAkebia Therapeutics, Inc.Nov 10, 2:36 AM ET·0001517022-25-000046
- 8-K265.7 KBAkebia Therapeutics, Inc.Nov 10, 2:04 AM ET·0001517022-25-000045
- 8-K210.1 KBAkebia Therapeutics, Inc.Oct 28, 4:37 PM ET·0001517022-25-000040
- 10-Q10.5 MBAkebia Therapeutics, Inc.Aug 7, 7:38 AM ET·0001628280-25-038600
- 8-K264.6 KBAkebia Therapeutics, Inc.Aug 7, 7:06 AM ET·0001517022-25-000034
- 8-K334.5 KBAkebia Therapeutics, Inc.Jun 13, 7:21 AM ET·0001517022-25-000030
- 10-Q9.5 MBAkebia Therapeutics, Inc.May 8, 7:29 AM ET·0001628280-25-023460
Insiders
10- ADAMS ADRIANDirector
- Amello JasonSVP, CFO & Treasurer
- Burke Steven KeithSVP, Chief Medical Officer
- Butler John P.Director, CEO and President
- Canute Scott ADirector
- Clayman Michael D.Director
- Cotreau ViolettaSVP, Chief Accounting Officer
- Dahan MichelSVP, Chief Business Officer
- Dalal AnupamDirector
- Enyedy Mark JDirector
Tickers
Addresses
business
245 FIRST STREET
CAMBRIDGE, MA, 02142
mailing
245 FIRST STREET
CAMBRIDGE, MA, 02142